Biotech
BMS reunites R&D divisions under Cristian Massacesi, while Robert Plenge departs
By Nick Paul Taylor
Nov 12, 2026 8:16am
The change reverses the structure BMS adopted following its 2019 takeover of Celgene. (James Waldron)
Bristol Myers Squibb is merging its research and development divisions under the leadership of Cristian Massacesi, M.D.
Starting Jan. 1, Massacesi—who is BMS’ chief medical officer and head of development—will lead a newly combined research and development unit as head of R&D. Meanwhile, the pharma's chief research officer, Robert Plenge, M.D., Ph.D., is leaving the company, although he will continue in an advisory capacity through March.
“Increasingly, traditional boundaries between research and development are collapsing,” BMS CEO Christopher Boerner, Ph.D., explained in a statement.…